Stocks

The table gives an overview of all stocks, alphabetically sorted.
 K-Fast Holding B KFASTB Mar 5, 2021 265.00 -2.07   
 K2A Knaust & Andersson Fastigheter B K2AB Mar 5, 2021 207.00 +1.47   
 K2A Knaust & Andersson Fastigheter Pref K2APREF Mar 5, 2021 335.00 +0.30   
 KABE Group B KABEB Mar 5, 2021 192.50 +8.15   
 Kakel Max KAKEL Mar 5, 2021 19.00 -1.55   
 Kallebäck Property Invest KAPIAB Mar 5, 2021 172.00 -0.29   
 Kambi Group KAMBI Mar 5, 2021 441.20 -5.12   
 Kancera KAN Mar 5, 2021 17.66 -1.23   
 Karnov Group KAR Mar 5, 2021 49.85 -1.68   
 Karo Pharma KARO Mar 5, 2021 50.20 -0.99   
 Karolinska Development B KDEV Mar 5, 2021 1.69 -2.31   
 KebNi B KEBNIB Mar 5, 2021 1.36 -1.45   
 Kentima Holding B KENH Mar 5, 2021 3.12 -3.70   
 Kid KIDO Mar 5, 2021 100.50 0.00   
 Kindred Group SDB KINDSDB Mar 5, 2021 130.25 -4.54   
 Kinnevik A KINVA Mar 5, 2021 452.50 -3.62   
 Kinnevik B KINVB Mar 5, 2021 385.00 -1.82   
 Kitron KITO Mar 5, 2021 17.36 0.00   
 Klaria Pharma Holding KLAR Mar 5, 2021 5.60 -2.78   
 Klimator KLIMAT Mar 5, 2021 22.00 -6.78   
 Klövern A KLOVA Mar 5, 2021 12.90 -2.27   
 Klövern B KLOVB Mar 5, 2021 12.69 -2.91   
 Klövern Pref KLOVPREF Mar 5, 2021 317.50 -0.31   
 KMC Properties ASA KMCPO Mar 5, 2021 8.15 0.00   
 Knowit KNOW Mar 5, 2021 270.00 -0.37   
 Kollect on Demand Holding KOLL Mar 5, 2021 8.32 +0.73   
 Komplett Bank KOMPO Mar 5, 2021 8.79 0.00   
 Kongsberg Automotive KOAO Mar 5, 2021 3.05 0.00   
 Kongsberg Gruppen KOGO Mar 5, 2021 175.00 0.00   
 Kontigo Care KONT Mar 5, 2021 5.84 -1.68   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK